Blog


Nicolò Briante

Nicolò Briante

Law graduate, with international experience of research in the field of Business Law at Cambridge University and UCL, Nicolò has been a student at Collegio Borromeo of Pavia and a great Medtech and Biotech enthusiast. He acquired experience in this field during a period spent in San Francisco as a selected student from the Mind the Bridge Start Up School. Founder & Ceo of D-Heart,...

Read More


Federica Girolami

Federica Girolami

FEDERICA Girolami Federica is Business Development, Scientific Liaison and Drug Safety Director at Rottapharm Biotech, where she is responsible for negotiations, alliances, and licensing activities. In her role as Scientific Liaison, she cultivates relationships with academic researchers and key opinion leaders. Given her long-standing experience in Pharmacovigilance, she is also responsible for all Drug Safety activities in Rottapharm Biotech’s Clinical Trials. Before joining Rottapharm, she...

Read More


Massimo Gulisano

Massimo Gulisano

Max is Professor of Applied Biology at University of Catania, Italy and director of the laboratory of Systems and Synthetic Biology at the Department of Drug Sciences. He is Medical Doctor with a PhD in Embryology. He was a researcher at CNR (I), MRC (UK), San Raffaele (I), and KCL (UK); he received a Mini-MBA™: Global BioPharma Entrepreneurship from Rutgers University, NJ (USA) in 2010....

Read More


Roberto Barzi

Roberto Barzi

Roberto is an investor in the biotech space, with +15 years of investing experience spanning from early stage to private equity deals across multiple geographies. He serves on the Board of multiple life-science companies throughout Europe and the US, including Vasopharm GmbH (Germany, traumatic brain injury), GNS Healthcare (Cambridge, digital health), Medinet (UK, outsourcing services). Roberto was a member of 3i’s Private Equity team in...

Read More


Alexander Zehnder

Alexander Zehnder

Alexander is the President and Managing director of Sanofi S.p.A, a leading multinational Pharma company with a large presence in Italy. After finishing his degree as Medical Doctor (MD) and getting an MBA from IMD, he has been working in the pharmaceutical industry for almost 20 years, in roles of increasing complexity and responsibility, some more product development focused, others more commercial, in different continents...

Read More


Francesco Maschio

Francesco Maschio

Pierfrancesco is CEO of Ricerchimica S.r.l. a consulting company focused on M&A and transaction services in Lifescience. He has over 25-year experience in Pharmaceuticals at European level with particular expertise in the Italian and Spanish market, where Ricerchimica was present, in Barcelona, with their own offices for over 5 years. Pierfrancesco has a wide experience in transaction, having worked on over 100 transactions of pharmaceutical...

Read More


Stefano Buono

Stefano Buono

Stefano Buono is an accomplished physicist and alumnus of The European Organization for Nuclear Research (CERN). Until January 2018, Mr. Buono served as Chief Executive Officer and board member of Advanced Accelerator Applications (AAA), an international radiopharmaceutical company he founded in 2002. The company traded under the ticker symbol AAAP, until it was acquired by Novartis for $3.9 billion. Mr. Buono still acts as a consultant for Novartis. Mr. Buono is...

Read More


Fabrizio De Simone

Fabrizio De Simone

Fabrizio runs the Italian Life Sciences Corporate Finance practice of EY (f.k.a. Ernst & Young) He has 19 years’ international experience in Corporate Finance, with main focus on M&A, coupled with a deep knowledge of Equity Capital Markets, Private Equity, Debt Advisory, Turnaround, Valuation and Business Modeling Fabrizio has a wealth of transaction experience across industries and geographies, having worked on over 70 transactions (mostly...

Read More


Chiara Zambon

Chiara Zambon

Chiara is Vice-President of the board of Zambon Company S.p.A., holding of the Group, member of the Board of Directors of Zambon S.p.A. and of ZaCh – Zambon Chemicals. She is also member of the Strategic Advisory Board of Zambon and followed, as member of the Board of Directors, from its origins in 2003, ZCube the incubator of Zambon Group. From 1989 to 1999 worked...

Read More


Elena Zambon

Elena Zambon

Elena is President President of Zambon S.p.A., Vice President of ZaCh (Zambon Chemicals) and member of the board of Zambon Company S.p.A., holding of the Group. In June 2014 she has been nominated Cavaliere del Lavoro and has received the award “Imprenditore Olivettiano 2010” and “Marisa Belisario 2010”. She is also President of Secofind, member of the Board of Director and the strategic Committee of...

Read More


Page 1 of 41234